gemcitabine 1 g powder for solution for infusion
fresenius kabi deutschland gmbh - gemcitabine - powder for solution for infusion - 1 gram(s) - pyrimidine analogues; gemcitabine
gemcitabine 2 g powder for solution for infusion
fresenius kabi deutschland gmbh - gemcitabine - powder for solution for infusion - 2 gram(s) - pyrimidine analogues; gemcitabine
gemcitabine 200 mg powder for solution for infusion
fresenius kabi deutschland gmbh - gemcitabine - powder for solution for infusion - 200 milligram(s) - pyrimidine analogues; gemcitabine
gemcitabine 38 mg/ml concentrate for solution for infusion
fresenius kabi deutschland gmbh - gemcitabine hydrochloride - concentrate for solution for infusion - 38 milligram(s)/millilitre - pyrimidine analogues; gemcitabine
fluorouracil teva
abic marketing ltd, israel - fluorouracil - solution for injection - fluorouracil 50 mg/ml - fluorouracil - fluorouracil - palliative management of carcinoma of the colon, rectum, breast, stomach and pancreas, in selected patients considered incurable by surgery or other means.as leucovorin-fluorouracil chemotherapy combination for cancer treatment.
fluorouracil ebewe 50 mgml
novartis israel ltd - fluorouracil - concentrate for solution for injection / infusion - fluorouracil 50 mg/ml - fluorouracil - fluorouracil - palliative management of carcinoma of the colon, rectum, breast, stomach and pancreas, in selected patients considered incurable by surgery or other means.as leucovorin-fluorouracil chemotherapy combination for cancer treatment.
efudix 5 %w/w cream
meda health sales ireland limited - fluorouracil - cream - 5 %w/w - pyrimidine analogues
vidaza powder for suspension for injection 100mgvial
bristol-myers squibb (singapore) pte. ltd. - azacitidine - injection, powder, for suspension - 100mg/vial - azacitidine 100mg/vial
fluorouracil 50 mg/ml solution for inj/inf
generics (uk) limited - fluorouracil - solution for inj/inf - 50 mg/ml - pyrimidine analogues - pyrimidine analogues - it is indicated in the treatment of the following malignancies and disease settings: in the treatment of metastatic colorectal cancer; as adjuvant treatment in colon and rectal cancer; in the treatment of advanced gastric cancer; in the treatment of advanced pancreatic cancer; in the treatment of advanced oesophageal cancer; in the treatment of advanced or metastatic breast cancer; as adjuvant treatment in patients with operable primary invasive breast cancer; in the treatment of inoperable locally advanced squamous cell carcinoma of the head and neck in previously untreated patients; in the treatment of locally recurrent or metastatic squamous cell carcinoma of the head and neck
agicil 50mg per ml 10ml vial
agila specialties uk limited - fluorouracil 50 mg/ml - solution for infusion or injection